How serpins change their fold for better and for worse

被引:24
作者
Carrell, RW [1 ]
Huntington, JA [1 ]
机构
[1] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England
来源
PROTEASES AND THE REGULATION OF BIOLOGICAL PROCESSES | 2003年 / 70卷
基金
英国医学研究理事会;
关键词
D O I
10.1042/bss0700163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serpins differ from the many other families of serine protease inhibitors in that they undergo a profound change in topology in order to entrap their target protease in an irreversible complex. The solving of the structure of this complex has now provided a video depiction of the changes involved. Cleavage of the exposed reactive centre of the serpin triggers an opening of the five-stranded A-sheet of the molecule, with insertion of the cleaved reactive loop as an additional strand in the centre of the sheet. The drastic displacement of the acyl-linked protease grossly disrupts its active site and gives an overall loss of 40% of ordered structure. This ability to provide effectively irreversible inhibition explains the selection of the serpins to control the proteolytic cascades of higher organisms. The conformational mechanism provides another advantage in its potential to modulate activity. Sequential crystallographic structures now provide clear depictions of the way antithrombin is activated on binding to the heparans of the microcirculation, and how evolution has utilized this mobile mechanism for subtle variations in activity. The complexity of these modulatory mechanisms is exemplified by heparin cofactor II, where the change in fold is seen to trigger multiple allosteric effects. The downside of the mobile mechanism of the serpins is their vulnerability to aberrant intermolecular beta-linkages, resulting in various disorders from cirrhosis to thrombosis. These provide a well defined structural prototype for the new entity of the conformational diseases, including the common dementias, as confirmed by the recent identification of the familial neuroserpin dementias.
引用
收藏
页码:163 / 178
页数:16
相关论文
共 78 条
  • [1] AULAK KS, 1993, J BIOL CHEM, V268, P18088
  • [2] Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism
    Baglin, TP
    Carrell, RW
    Church, FC
    Esmon, CT
    Huntington, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11079 - 11084
  • [3] BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515
  • [4] Antithrombins Wibble and Wobble (T85M/K): Archetypal conformational diseases with in vivo latent - Transition, thrombosis, and heparin activation
    Beauchamp, NJ
    Pike, RN
    Daly, M
    Butler, L
    Makris, M
    Dafforn, TR
    Zhou, A
    Fitton, HL
    Preston, FE
    Peake, IR
    Carrell, RW
    [J]. BLOOD, 1998, 92 (08) : 2696 - 2706
  • [5] Structural basis of the endoproteinase-protein inhibitor interaction
    Bode, W
    Huber, R
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2): : 241 - 252
  • [6] CRYSTAL-STRUCTURE ANALYSIS AND REFINEMENT OF 2 VARIANTS OF TRIGONAL TRYPSINOGEN - TRIGONAL TRYPSIN AND PEG (POLYETHYLENE-GLYCOL) TRYPSINOGEN AND THEIR COMPARISON WITH ORTHORHOMBIC TRYPSIN AND TRIGONAL TRYPSINOGEN
    BODE, W
    HUBER, R
    [J]. FEBS LETTERS, 1978, 90 (02) : 265 - 269
  • [7] THROMBOEMBOLIC DISEASE DUE TO THERMOLABILE CONFORMATIONAL-CHANGES OF ANTITHROMBIN ROUEN-VI (187-ASN-]ASP)
    BRUCE, D
    PERRY, DJ
    BORG, JY
    CARRELL, RW
    WARDELL, MR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) : 2265 - 2274
  • [8] ALPHA-1-ANTITRYPSIN AND THE SERPINS - VARIATION AND COUNTERVARIATION
    CARRELL, R
    TRAVIS, J
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1985, 10 (01) : 20 - 24
  • [9] Carrell R.W, 1986, PROTEINASE INHIBITOR, P403
  • [10] Conformational disease
    Carrell, RW
    Lomas, DA
    [J]. LANCET, 1997, 350 (9071) : 134 - 138